iPS cell transplants show early promise for treating Parkinson’s disease safely. A pioneering clinical trial in Japan reveals that stem cell-derived dopamine neurons can survive, function, and boost movement in Parkinson’s patients, without triggering serious side effects or abnormal growth.21-Apr-2025..
